Public Citizen in the Media
- July, 2013-MSF: Untangling the Web of Antiretroviral Price Reductions
- March 13, 2013- ICANN: Peter Maybarduk comments to ICANN regarding the National Association of Boards of Pharmacy’s application for the generic top level domain “.pharmacy” (links to gtldcomment.icann.org)
- February 28, 2013– Huffpost Live: Prescription to Die Live Segment, Featuring Peter Maybarduk (links to live.huffingtonpost.com)
- December 5, 2012– Open Society Foundations Blog: The Trans-Pacific Partnership: Closed Negotiations Against the Open Knowledge Economy (links to opensocietyfoundations.org)
- November 9, 2012– Leesburg Patch: Letter to the Editor by Peter Maybarduk: Medicines Monopoly (links to leesburg.patch.com)
- October 9, 2012-The Wall Street Journal: Letter to the Editor by Peter Maybarduk: Compassion, Risk and IP Protection (links to online.wsj.com)
- September 7, 2012-“WhatTPP Means for Digital Rights and Patients’ Rights”, listen to PublicCitizen’s Global Access to Medicines Program Director, Peter Maybarduk(2:26)
- July 25, 2012– Radio Australia: Interview with Peter Maybarduk: US trade policies hindering access to HIV-AIDS treatment (links to radioaustralia.net.au)
- May 10, 2012– Free Speech Radio News: Trade deal for Asia Pacific region could restrict medicine in poorer nations (links to fsrn.org)
- April 12, 2012– Huffington Post Blog: “Next SOPA” Going Global? (links to huffingtonpost.com)
- January 31, 2012– Webcast of Public Forum on IP and the Trans-Pacific FTA- Panel discussions of copyright provisions & provisions affecting access to medicines- Fast-forward to 1:33:15 for Global Access to Medicines Director Peter Maybarduk (links to infojustice.com)
- December 13, 2011– KPFA Radio Interview, featuring Global Access to Medicines Director Peter Maybarduk; Matt Kavanagh, HealthGAP; Ellen Shaffer, CPATH (recorded December 2nd, 2011)
- November 14, 2011– The Hill: Letter to the Editor from Global Access to Medicines in Response to PhRMA’s claims concerning the Trans-Pacific Partnership: PRMA falls short on explaining trade pact (links to thehill.com)
See More: Events | Presentations
Back to Access to Medicines Home Page